Esperas Pharma Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Esperas Pharma General Information

Description

Operator of a medical technology platform intended to offer biopharmaceutical products. The company's platform engages in developing an oral investigational medicine which specifically inhibits cancer cell division or unchecked proliferation, enabling healthcare professionals to avail a number of additional cancer indications with the goal of providing a clinical proof-of-concept of efficacy for cancer patients.

Contact Information

Website
www.esperasinc.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 810-1470 rue Peel
  • Montreal, Quebec H3A 1T1
  • Canada
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 810-1470 rue Peel
  • Montreal, Quebec H3A 1T1
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Esperas Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 21-Feb-2023 Completed Clinical Trials - Phase 1
1. Early Stage VC 13-Apr-2015 Completed Startup
To view Esperas Pharma’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Esperas Pharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fonds de solidarite FTQ PE/Buyout Minority
TVM Capital Life Science Venture Capital Minority
To view Esperas Pharma’s complete investors history, request access »

Ready to get started?

Request a free trial

Esperas Pharma FAQs

  • When was Esperas Pharma founded?

    Esperas Pharma was founded in 2015.

  • Where is Esperas Pharma headquartered?

    Esperas Pharma is headquartered in Montreal, Canada.

  • What industry is Esperas Pharma in?

    Esperas Pharma’s primary industry is Biotechnology.

  • Is Esperas Pharma a private or public company?

    Esperas Pharma is a Private company.

  • What is Esperas Pharma’s current revenue?

    The current revenue for Esperas Pharma is .

  • How much funding has Esperas Pharma raised over time?

    Esperas Pharma has raised $16.5M.

  • Who are Esperas Pharma’s investors?

    Fonds de solidarite FTQ and TVM Capital Life Science have invested in Esperas Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »